Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation for allegedly making misleading statements and failing to disclose material adverse facts regarding its business performance during the specified class period [1][3]. Group 1: Lawsuit Details - The lawsuit represents investors who acquired Integer securities from July 25, 2024, to October 22, 2025 [1]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Allegations Against the Company - The complaint claims that Integer overstated its competitive position and did not adequately disclose sales deterioration in its electrophysiology devices [3]. - The lawsuit also alleges that the company mischaracterized its growth drivers [3]. Group 3: Impact on Stock Price - Following the disclosure of reduced sales guidance and an expected sales decline on October 23, 2025, Integer's stock price fell by $35.22 per share, a decline of over 32% in one trading day [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Bitdeer Technologies Group due to alleged violations of federal securities laws related to misleading statements about the company's SEALMINER A4 project and its delayed chip production [4][5]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who suffered losses in Bitdeer between June 6, 2024, and November 10, 2025, to discuss their legal rights [1]. - A federal securities class action has been filed against Bitdeer, with a deadline of February 2, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that Bitdeer and its executives failed to disclose critical information regarding the SEAL04 chip's production timeline, which was expected to begin mass production in Q2 2025 [4]. Group 2: Financial Performance and Stock Impact - Bitdeer reported a third-quarter earnings per share of -$1.28, missing the consensus estimate of -$0.22, and disclosed significant delays in the development of its next-generation Seal 04 ASIC chip [5]. - Following the earnings report, Bitdeer's stock price fell by $2.63 per share, or 14.9%, closing at $15.02 on November 11, 2025 [5]. - A subsequent fire incident at Bitdeer's under-construction facility in Ohio led to another stock price drop of $2.83 per share, or 20.3%, closing at $11.11 on November 13, 2025 [6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Klarna Group plc due to allegations of violations of federal securities laws related to misleading statements and inadequate disclosures regarding loss reserves following its IPO [2][4]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in Klarna to contact them to discuss their legal options, particularly those who purchased securities in connection with Klarna's September 2025 IPO [1][2]. - A federal securities class action has been filed against Klarna, with a deadline of February 20, 2026, for investors to seek the role of lead plaintiff [2][6]. - The complaint alleges that Klarna materially understated the risk of increased loss reserves shortly after the IPO, which misled investors [4]. Group 2: Financial Performance and Market Reaction - Klarna reported a net loss of $95 million in its third quarter, while setting aside $235 million for loan loss provisions, exceeding analyst estimates of $215.8 million [5]. - Provisions for loan losses represented 0.72% of gross merchandise volume, an increase from 0.44% the previous year [5]. - Following the earnings report, Klarna's stock experienced a decline of 9.3% on November 18, 2025 [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Klarna Group plc due to allegations of violations of federal securities laws related to misleading statements and inadequate disclosures regarding loss reserves following its IPO [2][4]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in Klarna to contact them to discuss their legal options, particularly those who purchased securities in connection with Klarna's September 2025 IPO [1][2]. - A federal securities class action has been filed against Klarna, with a deadline of February 20, 2026, for investors to seek the role of lead plaintiff [2][6]. - The complaint alleges that Klarna and its executives materially understated the risk of increased loss reserves shortly after the IPO, which they either knew or should have known [4]. Group 2: Financial Performance and Market Reaction - Klarna reported a net loss of $95 million in its third quarter, while setting aside $235 million for loan loss provisions, which exceeded analyst estimates of $215.8 million [5]. - Provisions for loan losses represented 0.72% of gross merchandise volume, an increase from 0.44% a year ago, indicating a growing concern over credit risk [5]. - Following the announcement of these financial results, Klarna's stock fell by 9.3% on November 18, 2025 [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SLM Corporation due to allegations of violations of federal securities laws, particularly concerning misleading statements about the company's financial health and delinquency rates [2][4]. Group 1: Legal Investigation and Claims - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in SLM between July 25, 2025, and August 14, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against SLM, with a deadline of February 17, 2026, for investors to seek the role of lead plaintiff [2][6]. - The complaint alleges that SLM and its executives made false statements regarding the company's delinquency rates and the effectiveness of its loss mitigation programs [4]. Group 2: Financial Performance and Market Reaction - A report from TD Cowen on August 14, 2025, indicated that SLM's delinquencies increased by 49 basis points month-over-month, which was significantly worse than the expected seasonal increase of 10 basis points [5]. - Following the TD Cowen report, SLM's stock price dropped by $2.67 per share, or 8.09%, closing at $30.32 per share on August 15, 2025 [5]. Group 3: Company Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3].

Core Viewpoint - The complaint against Sprouts Farmers Market alleges that the company and its executives made misleading statements regarding the company's growth potential, which led to shareholders purchasing securities at inflated prices [2]. Financial Performance - On October 29, 2025, Sprouts reported a 4.3% decrease in comparable store growth compared to the previous quarter, which was below the company's earlier projections [3]. - The management projected a further reduction in comparable sales growth for the fourth quarter, estimating only 0%-2% growth, and revised full-year expectations down from 7.5%-9% to 7% [3]. - Following the announcement of these results, Sprouts' stock price dropped by $22.64, opening at $81.91 per share [3]. Legal Proceedings - The lead plaintiff in the class action lawsuit is the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [4]. - Any member of the putative class can move the court to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [4]. Call for Information - The law firm Faruqi & Faruqi encourages individuals with information regarding Sprouts' conduct, including whistleblowers and former employees, to come forward [5].

Core Viewpoint - Gauzy Ltd. announced the initiation of insolvency proceedings against three of its French subsidiaries, which has significant implications for its financial stability and operations [2][3]. Group 1: Company Financial Situation - The complaint alleges that three of Gauzy's French subsidiaries lacked the financial means to meet their debts as they became due, indicating a potential insolvency situation [2]. - The initiation of Redressement Judiciaire proceedings is intended to preserve operations and employment while formulating a recovery plan, but it also constitutes a default under the company's existing senior secured debt facilities [3]. Group 2: Market Reaction - Following the announcement of the insolvency proceedings, Gauzy's share price fell by $2.00 per share, nearly 50%, over two trading days, closing at $2.02 on November 17, 2025, with unusually heavy trading volume [4]. Group 3: Legal Proceedings - A lead plaintiff has been appointed for the class action lawsuit, representing the investor with the largest financial interest in the relief sought, and any member of the putative class may move the court to serve as lead plaintiff [5]. - The law firm Faruqi & Faruqi encourages individuals with information regarding Gauzy's conduct to come forward, including whistleblowers and former employees [6].

Core Viewpoint - A federal securities class action has been filed against Gauzy Ltd. for allegedly making materially false and misleading statements during the class period from March 11, 2025, to November 13, 2025 [1][2]. Allegations - The complaint alleges that Gauzy and certain officers failed to disclose that three French subsidiaries lacked sufficient financial resources to meet their obligations, leading to the initiation of French insolvency proceedings [2][8]. - The insolvency proceedings triggered a default under Gauzy's existing senior secured debt facilities and resulted in a delay in the release of its Third Quarter 2025 financial results [2][8]. Market Reaction - Following the disclosures regarding the insolvency proceedings, Gauzy's stock price fell approximately $2.00 per share, representing a decline of 49.8%, closing at $2.02 on November 17, 2025 [3]. Investor Deadlines - Investors have until February 6, 2026, to seek appointment as lead plaintiff in the class action [4]. Legal Representation - Wolf Haldenstein Adler Freeman & Herz LLP, a law firm with over 125 years of experience in securities litigation, is representing the investors affected by Gauzy's alleged misrepresentations [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Gauzy Ltd. due to allegations of violations of federal securities laws, particularly concerning misleading statements and undisclosed financial difficulties of its French subsidiaries [3][4]. Group 1: Company Financial Issues - Gauzy's three French subsidiaries reportedly lacked the financial means to meet their debts, leading to the likelihood of insolvency proceedings [3]. - The initiation of Redressement Judiciaire, a form of French insolvency proceedings, was announced on November 14, 2025, which constitutes a default under Gauzy's existing senior secured debt facilities [4]. - The company did not release its third-quarter 2025 financial results as scheduled due to these developments [4]. Group 2: Market Reaction - Following the announcement of insolvency proceedings, Gauzy's share price fell by $2.00 per share, nearly 50%, closing at $2.02 on November 17, 2025, with unusually high trading volume [5]. Group 3: Legal Proceedings - A federal securities class action has been filed against Gauzy, with a deadline of February 6, 2026, for investors to seek the role of lead plaintiff [1]. - The lead plaintiff is defined as the investor with the largest financial interest who directs the litigation on behalf of the class [6].

Core Viewpoint - Rezolute, Inc. experienced a significant decline in stock value following disappointing results from its Phase 3 clinical trial for its lead drug candidate, ersodetug, which failed to meet primary and key secondary endpoints [3][4]. Group 1: Company Performance - Rezolute's shares dropped sharply on December 11, 2025, with a decline from approximately $10.94 to an intraday low of around $0.90, representing an approximate 85-90% decrease [4]. - The Phase 3 sunRIZE clinical trial for ersodetug aimed at treating congenital hyperinsulinism did not achieve statistically significant reductions in hypoglycemia events compared to placebo [3]. Group 2: Legal Implications - Faruqi & Faruqi, LLP is investigating potential claims against Rezolute for investors who suffered significant losses due to the stock's decline [1][2].